Impact of Non-steroidal Anti-inflammatory Drugs, Glucocorticoids, and Disease-Modifying Anti-Rheumatic Drugs on Cancer Response to Immune Checkpoint Inhibitor Therapy.

导出 LinkOut

翻译打印收藏纠错

第一作者： Karmela K,Chan

第一单位： Department of Medicine, Division of Rheumatology, Hospital for Special Surgery, 535 East 70th Street, New York, NY 10021, USA; Department of Medicine, Division of Rheumatology, Weill Cornell Medicine. Electronic address: chanka@hss.edu.

作者： Karmela K,Chan ^[1] ; Anne R,Bass ^[2]

作者单位： Department of Medicine, Division of Rheumatology, Hospital for Special Surgery, 535 East 70th Street, New York, NY 10021, USA; Department of Medicine, Division of Rheumatology, Weill Cornell Medicine. Electronic address: chanka@hss.edu. ^[1] Department of Medicine, Division of Rheumatology, Hospital for Special Surgery, 535 East 70th Street, New York, NY 10021, USA; Department of Medicine, Division of Rheumatology, Weill Cornell Medicine. ^[2]

关键词 Checkpoint inhibitor Disease-modifying antirheumatic drugs Glucocorticoids Immune-related adverse events Nonsteroidal anti-inflammatory

主题词人类(Humans);糖皮质激素类(Glucocorticoids);肿瘤(Neoplasms);消炎药, 非甾类(Anti-Inflammatory Agents, Non-Steroidal);抗风湿药(Antirheumatic Agents);风湿性疾病(Rheumatic Diseases)

DOI 10.1016/j.rdc.2024.02.007

PMID 38670731

发布时间 2024-11-14

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交